A detailed history of Capital Asset Advisory Services LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Asset Advisory Services LLC holds 5,235 shares of LLY stock, worth $4.13 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
5,235
Previous 5,153 1.59%
Holding current value
$4.13 Million
Previous $4.67 Million 0.6%
% of portfolio
0.23%
Previous 0.26%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$772.14 - $960.02 $63,315 - $78,721
82 Added 1.59%
5,235 $4.64 Million
Q2 2024

Jul 24, 2024

SELL
$724.87 - $909.04 $264,577 - $331,799
-365 Reduced 6.61%
5,153 $4.67 Million
Q1 2024

Apr 16, 2024

BUY
$592.2 - $792.28 $117,255 - $156,871
198 Added 3.72%
5,518 $4.29 Million
Q4 2023

Jan 09, 2024

SELL
$525.19 - $619.13 $103,462 - $121,968
-197 Reduced 3.57%
5,320 $3.1 Million
Q3 2023

Oct 18, 2023

BUY
$434.7 - $599.3 $116,064 - $160,013
267 Added 5.09%
5,517 $2.96 Million
Q2 2023

Aug 02, 2023

BUY
$350.74 - $468.98 $91,543 - $122,403
261 Added 5.23%
5,250 $2.46 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $115,554 - $135,713
372 Added 8.06%
4,989 $1.71 Million
Q4 2022

Mar 08, 2023

BUY
$321.55 - $374.67 $264,957 - $308,728
824 Added 21.72%
4,617 $1.69 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $169,883 - $193,599
573 Added 17.8%
3,793 $1.23 Million
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $11,149 - $13,090
40 Added 1.26%
3,220 $1.04 Million
Q1 2022

Apr 29, 2022

BUY
$234.69 - $291.66 $89,182 - $110,830
380 Added 13.57%
3,180 $911,000
Q4 2021

Feb 04, 2022

BUY
$224.85 - $279.04 $20,236 - $25,113
90 Added 3.32%
2,800 $773,000
Q2 2021

Aug 06, 2021

SELL
$180.55 - $233.54 $33,943 - $43,905
-188 Reduced 6.49%
2,710 $622,000
Q1 2021

May 13, 2021

SELL
$164.32 - $212.72 $1,643 - $2,127
-10 Reduced 0.34%
2,898 $541,000
Q4 2020

Mar 02, 2021

SELL
$130.46 - $172.63 $1,304 - $1,726
-10 Reduced 0.34%
2,908 $491,000
Q3 2020

Nov 18, 2020

BUY
$146.22 - $169.13 $6,433 - $7,441
44 Added 1.53%
2,918 $432,000
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $13,505 - $16,253
99 Added 3.57%
2,874 $433,000
Q1 2020

May 18, 2020

SELL
$119.05 - $147.35 $3,214 - $3,978
-27 Reduced 0.96%
2,775 $438,000
Q4 2019

Feb 13, 2020

BUY
$106.92 - $132.43 $295,313 - $365,771
2,762 Added 6905.0%
2,802 $404,000
Q4 2019

Feb 12, 2020

BUY
$106.92 - $132.43 $4,276 - $5,297
40 New
40 $358,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capital Asset Advisory Services LLC Portfolio

Follow Capital Asset Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Asset Advisory Services LLC with notifications on news.